LITTLE KNOWN FACTS ABOUT AML WALLET RISK CHECK.

In spite of acquiring a complete reaction with exceptional induction therapy, nominal residual ailment usually persists, necessitating consolidation therapy to mitigate the risk of relapse by eradicating residual disease. In people who may have gained seven+3 induction therapy, consolidation therapy is initiated with higher-dose cytarabine, also c